Federal opioid agonist therapy policy: interrupted time series analysis of the impact of the methadone exemption removal across eight provinces in Canada
Federal drug regulation policy change interacted in complex ways with provincial health professional regulation and healthcare delivery, kaleidoscoping the effects of federal policy intervention. For Canada and other health systems such as the US, federal policy must account for significant subnational variation in OUD epidemiology and drug regulation to maximize intended beneficial effects and mitigate the risks of negative effects.
Authors
- Chloë Campbell (ORCID: https://orcid.org/0000-0002-0592-9949)
- Kellia Chiu (ORCID: https://orcid.org/0000-0002-4358-6641)
- Abhimanyu Sud (ORCID: https://orcid.org/0000-0001-8354-6153)
- Ross Upshur (ORCID: https://orcid.org/0000-0003-1128-0557)
- Arani Sivakumar (ORCID: https://orcid.org/0000-0003-4802-045X)
- Rahim Moineddin (ORCID: https://orcid.org/0000-0002-5506-084X)
Institutions
- Western University (CA)
- The University of Sydney (AU)
- University of Toronto (CA)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Humber River Regional Hospital (CA)
- Public Health Ontario (CA)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s12913-024-11281-9
- Citations
- 3
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Health Canada
- Canadian Institutes of Health Research